Vaccine confusion as clots force jab switch for two million

17 June 2021 - Health authorities are scrambling to switch more than two million Australians aged under 60 to the ...

Read more →

Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick disease type C

18 June 2021 - Orphazyme today announced it has received a complete response letter from the U.S. FDA following its ...

Read more →

Outcomes of the May 2021 PBAC intracycle meeting

18 June 2021 - The outcomes from the May 2021 PBAC meeting are now available. ...

Read more →

Efficient funding of chemotherapy review - submissions on discussion paper

18 June 2021 - The efficient funding of chemotherapy review discussion paper was released on 21 May 2021 to gain ...

Read more →

Let's have permanently quicker drug approvals

16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we ...

Read more →

Furore rages over FDA approval of controversial Alzheimer’s drug

17 June 2021 - Critics attack the agency’s action as reckless, but defenders say patients will benefit. ...

Read more →

Dupixent (dupilumab) pre-filled pen now available in Canada, providing convenient self-administration option for people with type 2 inflammatory diseases

17 June 2021 - The pre-filled pen offers an additional administration option for all Dupixent indications in patients aged 12 years ...

Read more →

The FDA is in desperate need of some soul-searching

17 June 2021 - Ordinarily, the approval of a new drug for a dreaded disease affecting millions of Americans would be ...

Read more →

Amneal announces U.S. FDA filing acceptance of biologics license application for bevacizumab

17 June 2021 - Bevacizumab represents the third biosimilar BLA currently filed by Amneal with the FDA. ...

Read more →

Agenus announces U.S. FDA acceptance and priority review of balstilimab biologics license application for the treatment of recurrent or metastatic cervical cancer

17 June 2021 - Agenus today announced that the U.S. FDA has accepted Agenus’ biologics license application for balstilimab, an ...

Read more →

FDA approves a nasal anti-histamine for non-prescription use

17 June 2021 - The U.S. FDA today approved a nasal antihistamine for nonprescription use through a process called a partial ...

Read more →

Applied Therapeutics granted fast track designation by FDA for AT-007 for galactosaemia

17 June 2021 - Applied Therapeutics today announced that the U.S. FDA has granted fast track designation to AT-007 for the ...

Read more →

Shared decision making underpins good health care

17 June 2021 - Shared decision making between service users and health care professionals is an integral part of health care, ...

Read more →

A life-saving new drug for COVID-19 is found

16 June 2021 - But only rich countries will benefit, and even they will struggle to get hold of it. ...

Read more →

Eagle Pharmaceuticals submits response to complete response letter from FDA for vasopressin

17 June 2021 - Eagle Pharmaceuticals today announced that it has responded to the complete response letter for its abbreviated ...

Read more →